Last edition
News about "Licensing "
Chugai Pharma concludes licence agreement with Roche for CT-388
Chugai Pharmaceutical has signed a licensing deal with F. Hoffmann-La Roche for CT-388, a long-acting GLP-1/GIP receptor agonist for obesity and type-II diabetes, granting Chugai exclusive development and marketing rights in Japan.
Licensing | 11/10/2025 | By Dineshwori | 307
Alkem Laboratories Signs Licensing Deal with Sonnet BioTherapeutics
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet and enable global and India regulatory filings.
Licensing | 10/10/2024 | By Aishwarya | 367
Zydus Signs Licensing and Supply Agreement with Viwit Pharmaceuticals
As per the terms of the agreement, Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTM and DOTAREM, following the receipt of requisite regulatory approval.
Licensing | 16/09/2024 | By Aishwarya | 470
Biocon Signs Exclusive Deal for Commercializing Liraglutide in South Korea with Handok
Biocon Ltd. has signed an exclusive licensing and supply agreement with Handok, a specialty pharmaceutical company in South Korea, for the commercialization of its vertically integrated, complex drug product, Synthetic Liraglutide.
Licensing | 28/05/2024 | By Aishwarya | 598
DelSiTech Enters into Licensing Deal with Global Pharma Firm for Drug Delivery
DelSiTech Ltd. has entered into a Licensing Agreement with an undisclosed global pharmaceutical company.
Licensing | 23/05/2024 | By Aishwarya | 550
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy